These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

121 related items for PubMed ID: 1878678

  • 1. Relative toxicity of two different conditioning regimens in patients undergoing allogeneic bone marrow transplantation.
    Romeiras M, Rodrigues AS, Machado A, Jorge L, Nolasco I, Abecasis M.
    Bone Marrow Transplant; 1991; 7 Suppl 2():133. PubMed ID: 1878678
    [No Abstract] [Full Text] [Related]

  • 2. Escalating doses of etoposide with cyclophosphamide and fractionated total body irradiation or busulfan as conditioning for bone marrow transplantation.
    Spitzer TR, Cottler-Fox M, Torrisi J, Cahill R, Greenspan A, Lynch M, Deeg HJ.
    Bone Marrow Transplant; 1989 Sep; 4(5):559-65. PubMed ID: 2676044
    [Abstract] [Full Text] [Related]

  • 3. Hemorrhagic cystitis after allogeneic bone marrow transplantation for thalassemia.
    Erer B, Angelucci E, Baronciani D, Tomasucci M, Giardini C, Gaziev J.
    Bone Marrow Transplant; 1993 Sep; 12 Suppl 1():93-5. PubMed ID: 8374576
    [No Abstract] [Full Text] [Related]

  • 4. Bone marrow transplantation from matched related donors for patients with Fanconi anemia using low-dose busulfan and cyclophosphamide as conditioning.
    Torjemane L, Ladeb S, Ben Othman T, Abdelkefi A, Lakhal A, Ben Abdeladhim A.
    Pediatr Blood Cancer; 2006 Apr; 46(4):496-500. PubMed ID: 16333862
    [Abstract] [Full Text] [Related]

  • 5. [Whole-body irradiation for bone marrow transplantation].
    Di Pietrantonj F, Proietti A, Capirci C.
    Radiol Med; 1984 Jun; 70(6):396-410. PubMed ID: 6398469
    [Abstract] [Full Text] [Related]

  • 6. Gonadal function in adolescents receiving different conditioning regimens for bone marrow transplantation.
    Giorgiani G, Bozzola M, Cisternino M, Locatelli F, Gambarana D, Bonetti F, Zecca M, Lorini R, Severi F.
    Bone Marrow Transplant; 1991 Jun; 8 Suppl 1():53. PubMed ID: 1760641
    [No Abstract] [Full Text] [Related]

  • 7. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 8. The development of busulfan/cyclophosphamide preparative regimens.
    Santos GW.
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):12-6; quiz 17. PubMed ID: 8342070
    [Abstract] [Full Text] [Related]

  • 9. Randomized trial of busulfan vs total body irradiation containing conditioning regimens for children with acute lymphoblastic leukemia: a Pediatric Blood and Marrow Transplant Consortium study.
    Bunin N, Aplenc R, Kamani N, Shaw K, Cnaan A, Simms S.
    Bone Marrow Transplant; 2003 Sep; 32(6):543-8. PubMed ID: 12953124
    [Abstract] [Full Text] [Related]

  • 10. Can busulfan replace fractionated total body irradiation as conditioning regimen for allogeneic bone marrow transplantation in children with acute lymphoblastic leukemia.
    Wachowiak J, Bettoni C, Lange A, Malicki J, Kaczmarek-Kanold M, Głuszak B, Suchnicki K, Daszkiewicz P, Ebell W.
    Acta Haematol Pol; 1995 Sep; 26(4):377-84. PubMed ID: 8571739
    [Abstract] [Full Text] [Related]

  • 11. Allogeneic bone marrow transplantation for acute myelogenous leukemia, acute lymphocytic leukemia, and multiple myeloma following preparation with busulfan and cyclophosphamide (BuCy2).
    Copelan EA, Biggs JC, Szer J, Thompson JM, Crilley P, Brodsky I, Klein JL, Kapoor N, Harman GS, Avalos BR.
    Semin Oncol; 1993 Aug; 20(4 Suppl 4):33-8; quiz 39. PubMed ID: 8342074
    [Abstract] [Full Text] [Related]

  • 12. Allogeneic bone marrow transplantation for children with acute lymphoblastic leukemia conditioned with busulfan, cyclophosphamide and melphalan.
    Carpenter PA, Marshall GM, Giri N, Vowels MR, Russell SJ.
    Bone Marrow Transplant; 1996 Sep; 18(3):489-94. PubMed ID: 8879607
    [Abstract] [Full Text] [Related]

  • 13. Haemorrhagic cystitis in bone marrow transplantation patients: possible increased risk associated with prior busulphan therapy.
    Thomas AE, Patterson J, Prentice HG, Brenner MK, Ganczakowski M, Hancock JF, Pattinson JK, Blacklock HA, Hopewell JP.
    Bone Marrow Transplant; 1987 Apr; 1(4):347-55. PubMed ID: 3139113
    [Abstract] [Full Text] [Related]

  • 14. Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
    Kanfer EJ, Buckner CD, Fefer A, Storb R, Appelbaum FR, Hill RS, Amos D, Doney KC, Clift RA, Shulman HM.
    Bone Marrow Transplant; 1987 Apr; 1(4):339-46. PubMed ID: 3332142
    [Abstract] [Full Text] [Related]

  • 15. Cyclophosphamide, cytosine arabinoside and TBI as a conditioning regimen for allogeneic bone marrow transplantation in patients with leukemia.
    Jillella AP, Doria R, Khan K, Zelterman D, Ahmad YH, Smith BR, Holmes W, Becker P, Roberts KB, Rappeport JM.
    Bone Marrow Transplant; 1999 Jun; 23(11):1095-100. PubMed ID: 10382947
    [Abstract] [Full Text] [Related]

  • 16. Total body irradiation and high-dose cyclophosphamide, BCNU and VP-16 (CBV) as a new preparatory regimen for allogeneic bone marrow transplantation in patients with advanced hematologic malignancies.
    Wu DP, Milpied N, Moreau P, Mechinaud-Lacroix F, Mahe B, Le Tortorec S, Rapp MJ, Bourdin S, Mahe JM, Harousseau JL.
    Bone Marrow Transplant; 1994 Nov; 14(5):751-7. PubMed ID: 7889008
    [Abstract] [Full Text] [Related]

  • 17. Eosinophilia after allogeneic bone marrow transplantation using the busulfan and cyclophosphamide preparative regimen.
    Kalaycioglu ME, Bolwell BJ.
    Bone Marrow Transplant; 1994 Jul; 14(1):113-5. PubMed ID: 7951097
    [Abstract] [Full Text] [Related]

  • 18. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T, Murayama S, Ohtani M, Shibata H, Masaoka T.
    Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
    [Abstract] [Full Text] [Related]

  • 19. Use of busulfan containing chemotherapy for conditioning patients with leukemia for bone marrow allografting.
    Tutschka PJ.
    Bone Marrow Transplant; 1993 Apr; 12 Suppl 1():34-6. PubMed ID: 8374557
    [No Abstract] [Full Text] [Related]

  • 20. Replacing total body irradiation with busulfan as conditioning of patients with leukemia for allogeneic marrow transplantation.
    Tutschka PJ, Copelan EA, Kapoor N.
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2952-4. PubMed ID: 2650402
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.